MDGL
NASDAQStockMadrigal Pharmaceuticals, Inc.
$446.27+7.54 (+1.72%)
52-Week Range
$267.56
$602.83
Key Stats
Market Cap
10.1B
P/E Ratio
—
Dividend Yield
—
Beta
-0.96
Volume
144.4K
Avg Volume
347.4K
Performance
1M
-7.40%
3M
-21.73%
6M
+3.09%
YTD
-26.12%
1Y
+25.95%
3Y
+83.72%
5Y
+275.75%
Price Chart
ETF Exposure
MDGL is held by 140 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.01% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.01% |
| SCHB | Schwab U.S. Broad Market ETF | 0.01% |
| SPGM | State Street SPDR Portfolio MSCI Global Stock Market ETF | 0.01% |
| GUSA | Goldman Sachs MarketBeta US 1000 Equity ETF | 0.01% |
| V3AL.L | Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.01% |
| V3AM.L | Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.01% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.01% |
| VT | Vanguard Total World Stock ETF | 0.01% |
| JHML | John Hancock Investments - Multifactor Large Cap ETF | 0.01% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.01% |
| XUU.TO | iShares Core S&P U.S. Total Market Index ETF | 0.01% |
| GTPE | Goldman Sachs MSCI World Private Equity Return Tracker ETF | 0.01% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.01% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.01% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.01% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.01% |
| XEQT.TO | iShares Core Equity ETF Portfolio | 0.01% |
| ZPRV.DE | State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETF | 0.01% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| EAOA | iShares ESG Aware 80/20 Aggressive Allocation ETF | 0.00% |
| EAOR | iShares ESG Aware 60/40 Balanced Allocation ETF | 0.00% |
| IALT | iShares Systematic Alternatives Active ETF | 0.00% |
| IMID.L | State Street SPDR MSCI All Country World Investable Market UCITS ETF (Acc) | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| SPYI.DE | State Street SPDR MSCI All Country World Investable Market UCITS ETF (Acc) | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| AVSU | Avantis Responsible U.S. Equity ETF | 0.00% |
| EAOK | iShares ESG Aware 30/70 Conservative Allocation ETF | 0.00% |
| EAOM | iShares ESG Aware 40/60 Moderate Allocation ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
| IQSM | NYLI Candriam U.S. Mid Cap Equity ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
PreviousPage 3 of 3
About MDGL ETF Exposure
Madrigal Pharmaceuticals, Inc. (MDGL) is held by 140 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 10.1B, MDGL is a widely held institutional stock. The stock currently trades at $446.27. Investors can gain exposure to MDGL through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold MDGL, sorted by portfolio weight.